A specialist life-sciences model with published pricing and broader controlled access. It belongs on a governed research shortlist, but Workbench remains in preview and independent same-task scientific, cost and reliability testing is pending.
Research teams have a published API price and broader route to evaluation, but access remains controlled and Rosalind Workbench is still in research preview.
OpenAI GPT‑Rosalind update ↗GPT‑Rosalind is designed for eligible life-sciences organisations testing governed research workflows across biology, drug discovery and translational medicine. HubAI treats it as a workflow purchase rather than a novelty: the relevant question is whether it produces an acceptable result repeatedly, with controls your team can understand and a cost that remains predictable after the trial ends.
Eligible life-sciences organisations testing governed research workflows across biology, drug discovery and translational medicine
material claims supported by opened, relevant primary sources
Access requires organisational approval and trusted-access review
Audit ten output claims against the cited paper or primary publication.
Bring one representative input
Run the same job three times
Measure accepted output and cost
OpenAI limits GPT‑Rosalind to approved internal research through trusted access. Review retention, model-training terms, access management, auditability and data-processing region for the contracted route before using proprietary research data.
Available globally to eligible organisations through ChatGPT, Codex and the API after qualification and safety review. The published API identifier is gpt-rosalind-research; Rosalind Workbench remains in research preview.
ChatGPT · Codex · OpenAI API · Life Sciences research plugin · 50+ scientific tools and data sources
Vendor facts and HubAI opinion are separated. Sponsored placement cannot buy a higher score.
One compact record for price, access, data handling, deployment and the test that must pass before adoption.
OpenAI limits GPT‑Rosalind to approved internal research through trusted access. Review retention, model-training terms, access management, auditability and data-processing region for the contracted route before using proprietary research data.
Available globally to eligible organisations through ChatGPT, Codex and the API after qualification and safety review. The published API identifier is gpt-rosalind-research; Rosalind Workbench remains in research preview.
ChatGPT · Codex · OpenAI API · Life Sciences research plugin · 50+ scientific tools and data sources
Freeze one representative scientific workflow and compare accepted conclusions, source traceability, tool-call failures, expert correction time and complete cost with the current process. Do not treat vendor benchmarks as an independent result.
HubAI will publish a score only after the same representative tasks have been run against current alternatives. Vendor benchmarks are not treated as an editorial rating.
The subscription price is only the starting point. HubAI evaluates usage limits, failed attempts and the work needed to produce one usable result. Pricing changes frequently, so the structure and verification date matter more than a headline price.
Pricing checked for editorial use on 4 September 2026. Confirm live price, VAT, region, usage rights and cancellation terms with the vendor before purchase.
Model your own usage. HubAI separates subscription cost from retries and human review—without pretending a headline plan price tells the whole story.
Test this job with your own inputs and judge the finished result—not the first draft.
Test this job with your own inputs and judge the finished result—not the first draft.
Test this job with your own inputs and judge the finished result—not the first draft.
Act as a specialist in research ai. Ask me three questions before creating the first draft. The outcome I need is: [describe outcome].Create two approaches for [task]. Use this audience: [audience]. Respect these constraints: [constraints]. Explain the trade-off between the two approaches.Review this output against accuracy, tone, privacy, cost and usability. List the changes required before a person should approve it.Do not place confidential, personal or rights-restricted material into GPT‑Rosalind until your organisation has reviewed its current terms, retention settings and account controls. AI output can be plausible and still wrong; regulated, financial, legal and employment decisions require qualified human review.
This is HubAI's editorial record, not the vendor's product changelog or a live uptime claim.
Use-case routes, relevant comparisons and alternatives connected to the product profile.
Entry price structure, free or trial route and buyer limitations checked for editorial use.
Verdict, best fit, strengths, limitations, prompts and governance questions structured.
Scores are editorial signals, not a universal winner. Choose around the exact job and run the same proof test.
| Product | HubAI score | Best for | Price structure | Access | Decision |
|---|---|---|---|---|---|
| GPT‑Rosalind CURRENT | Test pending | Eligible life-sciences organisations testing governed research workflows across biology, drug discovery and translational medicine | $5/1M input, $0.50/1M cached input and $25/1M output tokens from 5 October 2026; tools and compute are additional | No self-service trial; global access for eligible organisations requires trusted-access qualification and safety review | Current profile |
| Perplexity | 9/10 | Source-led web research, fast briefings and answer-engine discovery | Free; Pro and business plans | Free tier | Compare → |
| Elicit | 8.8/10 | Structured literature reviews and evidence extraction from research papers | Free entry; paid research plans | Free basic workflow | Compare → |
| Consensus | 8.6/10 | Fast evidence-led answers grounded in academic research | Free entry; paid premium plans | Free search allowance | Compare → |
GPT‑Rosalind is best suited to eligible life-sciences organisations testing governed research workflows across biology, drug discovery and translational medicine. HubAI's current verdict is: A specialist life-sciences model with published pricing and broader controlled access. It belongs on a governed research shortlist, but Workbench remains in preview and independent same-task scientific, cost and reliability testing is pending.
No self-service trial; global access for eligible organisations requires trusted-access qualification and safety review. Check the official product page before buying because allowances, regions and eligibility can change.
$5/1M input, $0.50/1M cached input and $25/1M output tokens from 5 October 2026; tools and compute are additional. The useful comparison is total cost per accepted result, including retries, limits and human correction—not the advertised entry price alone.
Compare products in the same Research AI shelf against one identical task, acceptance rule and cost window. Focus on material claims supported by opened, relevant primary sources.
Rate this product and share what really happened. Every review is checked before it appears publicly.
If you used GPT‑Rosalind, share its quality, pricing, trial experience and real result. Useful specifics beat empty praise.
Sign in to leave a rating and review.
Sign in to reviewNo approved user reviews yet. Be the first to leave a useful one.